Skip to main content
. 2013 Jul 10;2013:807849. doi: 10.1155/2013/807849

Figure 3.

Figure 3

Relative PLAC1 expression among endometrial tumor types (left) and between tumor stages (right). Fold changes, assessed by ΔΔCt, between endometrioid adenocarcinoma (EA) and serous adenocarcinoma (SA) and between endometrioid adenocarcinoma (EA) and carcinosarcoma (CS) are 6.58 and 16.47, respectively. PLAC1 fold change between Stage 1 and 2 tumors (S1/2) and Stage 3 (S3) tumors is 10.41. Statistical significance is assessed by a two-tailed t-test with unequal variances using normalized expression values (ΔCt). Sample sizes are shown.